Navigation Links
GP bodies support guidelines for use of patient records in medical research
Date:6/28/2009

The two leading bodies representing GPs in the UK have backed a call by the Wellcome Trust for clearer guidance for GPs to ensure medical records can be safely used in research.

Patient records in general practice surgeries are a unique resource of information which can help medical researchers improve their understanding of disease, develop potential new treatments and improve patient care. The increasing use of electronic records should make it easier for researchers to use this information.

The public are generally supportive of this research: two-thirds of people would consider allowing personal health information to be shared for research purposes. However, this information is both sensitive and private and the public, patients and healthcare professionals must all have confidence that the security of personal information is safeguarded.

Today, the Wellcome Trust, the UK's largest medical research charity, publishes guidelines for best practice in the use of patient records for research purposes. The report was reached during a national consensus meeting held in 2008 with GPs, researchers and patient groups.

The guidelines Towards Consensus for Best Practice have been endorsed by the British Medical Association (BMA), the independent trade union and professional association for doctors and medical students, and the Royal College of General Practitioners (RCGP), the professional membership body for family doctors in the UK and abroad.

Three overarching principles form the basis on which the guidelines were agreed. They are:

  1. Patient confidentiality and privacy must be safeguarded
  2. GPs and healthcare professionals should play the role of patient's advocate
  3. Public awareness and understanding of the use of records in research should be improved.

"We welcome the endorsement by the BMA and the Royal College of General Practitioners of the guidelines for the use of patient re
'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MMR Information Systems, Inc. Receives Licensing Proposal Involving the Companys Anti-CD20 Antibodies
2. Autoantibodies may be created in response to bacterial DNA
3. Beverly Hills Cosmetic Plastic Surgeon Andrew T. Cohen, MD Helping New Moms Restore their Bodies with a Mommy Makeover
4. ForteBio Launches New Biosensor for Kinetic Analysis and Screening of Human IgG Antibodies
5. Orange County Plastic Surgeon Dr. Semira Bayati Helping Women Restore their Bodies after Childbirth with Mommy Makeover
6. South Carolina Plastic Surgeon Helps New Moms Restore their Bodies with a Mommy Makeover
7. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
8. Strong Bodies Battle Better
9. Biosimilar Monoclonal Antibodies in Oncology Will Approach Blockbuster Status by 2017
10. Playboy founder embodies American Dream; changes American culture
11. Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Baxa IntelliFlowRx 28TM 29 Upgrades Expand Pharmacy Capabilities 57968 1Baxa IntelliFlowRx 28TM 29 Upgrades Expand Pharmacy Capabilities 57968 2Baxa IntelliFlowRx 28TM 29 Upgrades Expand Pharmacy Capabilities 57968 3Oracle OpenWorld 2009 Panel to Feature Two Experts from National Healthcare Leadership Organizations the FDA and GS1 Healthcare US with Loftware 57966 1Oracle OpenWorld 2009 Panel to Feature Two Experts from National Healthcare Leadership Organizations the FDA and GS1 Healthcare US with Loftware 57966 2Oracle OpenWorld 2009 Panel to Feature Two Experts from National Healthcare Leadership Organizations the FDA and GS1 Healthcare US with Loftware 57966 3National Council on Disability to Recommend Health Care Changes for People With Disabilities 57964 1
Other Medicine Technology:Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 2Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 3Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 4Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 5Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 6Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 7Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 8Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 9Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 10Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 11Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 12Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 2Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 3Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 4